Novo’s Weight Loss Drugs Removed from FDA Shortage List
The FDA said weight-loss and diabetes drugs Wegovy and Ozempic are no longer on shortage list. The U.S. Food and Drug ...
Prediction: These Could Be the Best-Performing Value Stocks Through 2030
These two stocks are poised to crush the market thanks to their outsize growth prospects and dirt cheap valuations.
WTVF22h
FDA announces end to Wegovy and Ozempic drug shortages, but it could mean higher prices
The FDA has announced that the shortage of Wegovy and Ozempic, medications used for weight loss and diabetes management, is ...
조선일보15h
Korea hosts APEC science and technology cooperation assembly in Gyeongju
Korea hosts APEC science and technology cooperation assembly in Gyeongju Asia-Pacific nations set to enhance scientific ...
pharmaphorum20h
Novo rises on Wegovy sales leap, but warns of a slowdown
Novo Nordisk's obesity therapy Wegovy put in another strong sales performance in the final quarter of last year, helping to drive group revenue growth of 30% – but don't expect that breakneck ...